Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 29 tags : Alzheimer's save search
Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.24%
H: 0.58%
C: -1.74%
disease alzheimer alzheimer’s alzheimer's disease alzheimer's designation
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease
Published: 2021-07-29 (Crawled : 14:00) - globenewswire.com
SAVA M | $20.75 0.97% 0.96% 480K
|
Health Technology
|
| O: 7.17%
H: 0.8%
C: -28.72%
disease alzheimer positive alzheimer’s alzheimer's disease alzheimer's
Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer’s Disease
Published: 2021-07-29 (Crawled : 14:00) - globenewswire.com
SAVA M | $20.75 0.97% 0.96% 480K
|
Health Technology
|
| O: 7.17%
H: 0.8%
C: -28.72%
disease alzheimer positive alzheimer’s alzheimer's disease alzheimer's biomarkers
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Significantly Prevented Aβ (Abeta)-induced Cognitive Deficits with Confirmed Significant Biomarker-response in Animal Model of Alzheimer’s Disease
Published: 2021-07-29 (Crawled : 11:00) - anavex.com
AVXL | $3.4 -7.61% -8.24% 2M
|
Health Technology
|
| O: 2.67%
H: 0.27%
C: -16.6%
disease alzheimer life science anavex®2-73 anavex alzheimer’s alzheimer's disease alzheimer's biomarkers
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.